Comparison of the effects of potassium citrate and hydrochlorothiazide on the stone formation rate of ureteral stent in patients with prolonged stent insitue
Phase 3
- Conditions
- ureteral stent complication :stent encrustation.Other mechanical complication of urinary stent, initial encounterT83.192A
- Registration Number
- IRCT20180625040232N3
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Patients who have 18-65 years old under went urologic surgeries which needs ureteral stent insitu for 4weeks
absence of urinary tract infection
Absence of metabolic abnormality such as primary or secondary hyperparathyroidism,
absence of Ca and Vitamin D supplements usages
Exclusion Criteria
Patient age less than 18 or more than 60
stent placement for less than 4 weeks
urinary tract infection
metabolic abnormality such as primary or secondary hyperparathyroidism,
Ca and Vitamin D supplements usages
patients who do not have intend to use Drugs that are prescribed for Stone formation prevention
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stent Encrustation. Timepoint: 4 weeks after ureteral stent insertion. Method of measurement: observation of ureteral stent encrustation during stent extraction with difficult stent extraction due to stent encrustation.
- Secondary Outcome Measures
Name Time Method Stent insitu duration. Timepoint: End of intervention ,at the time of stent extraction. Method of measurement: By reviewing the date of surgery and stent insertion from the summary chart at the time of referring to stent extraction.